← Back to Clinical Trials
Recruiting NCT06953622
Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale
Trial Parameters
Condition Migraine
Sponsor Peking University Third Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 330
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2024-01-01
Completion 2026-12-31
All Conditions
Interventions
Conservative treatmentAntipaletet drugPatent Foramen Ovale Closure
Brief Summary
To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent foramen ovale, and search for the possible influencing factors, construct models that influence prognosis.
Eligibility Criteria
Inclusion Criteria: * Meet the diagnostic criteria for migraine in the International Classification of Headache (ICHD-3); * Confirmation of patent foramen ovale through transthoracic echocardiography(TTE) or transesophageal echocardiography(TEE)/right heart contrast echocardiography * Agree to participate in the study and sign the informed consent form. Exclusion Criteria: * Can not sign the informed consent form or cooperate with follow-up.